APNHY (Aspen Pharmacare Holdings) 6-Month Price Index: 1.23 (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APNHY Aspen Pharmacare Holdings Ltd APNHY
70 GF Score
Price $9.72
GF Value $10.02
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings 6-Month Price Index?

Aspen Pharmacare Holdings APNHY -0.10% 70 6-Month Price Index is 1.23 as of Sep. 16, 2026. GuruFocus rates APNHY with a GF Score™ of 70/100 and a GF Value™ of $10.02 (Fairly Valued). The stock has 10 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-16), Aspen Pharmacare Holdings's 6-Month Price Index is 1.23.

Aspen Pharmacare Holdings  (OTCPK:APNHY) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Aspen Pharmacare Holdings 6-Month Price Index Related Terms

APNHY vs ZTS, UTHR, VTRS: 6-Month Price Index Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

APNHY
70GF Score
Aspen Pharmacare Holdings Ltd APNHY
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings  (OTCPK:APNHY) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.23 mean?
Aspen Pharmacare Holdings (APNHY) has a 6-Month Price Index of 1.23 as of Sep. 16, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Aspen Pharmacare Holdings and its competitors.
Is Aspen Pharmacare Holdings' 6-Month Price Index too high?
Aspen Pharmacare Holdings' current 6-Month Price Index is 1.23. Overall, Aspen Pharmacare Holdings has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' 6-Month Price Index compare to ZTS and UTHR?
Aspen Pharmacare Holdings' 6-Month Price Index of 1.23 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Drug Manufacturers company?
A good 6-Month Price Index depends on the Drug Manufacturers industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Aspen Pharmacare Holdings and its competitors. Aspen Pharmacare Holdings's current 6-Month Price Index is 1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (APNHY) is currently considered Fairly Valued. The stock's GF Value™ is $10.02, compared to a current price of $9.72 — trading 3% below its estimated fair value. The current 6-Month Price Index is 1.23. Aspen Pharmacare Holdings' overall GF Score™ is 70/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Aspen Pharmacare Holdings (APNHY), the current 6-Month Price Index is 1.23 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Pharmacare Holdings (APNHY) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of $9.72 is trading 3% below its estimated GF Value™ of $10.02. GuruFocus considers Aspen Pharmacare Holdings to be Fairly Valued.

Key valuation signals for APNHY:

  • 6-Month Price Index: 1.23
  • GF Value™: $10.02 vs. price of $9.72 (3% below fair value)
  • GF Score™: 70/100 with 10 warning signs

No single metric tells the full story. See the APNHY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
70GF Score

Get the complete analysis for APNHY

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.72
Price
$10.02
GF Value